@article{83a3a4fc2a9140a38d8cf069d39f818c,
title = "European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis",
keywords = "Advisory Committees, COVID-19, Comorbidity, Coronavirus Infections/epidemiology, Dermatitis, Atopic/drug therapy, Europe, Female, Humans, Immunocompromised Host/drug effects, Immunosuppressive Agents/therapeutic use, Male, Pandemics, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic, Risk Assessment, Severe Acute Respiratory Syndrome/epidemiology, Treatment Outcome",
author = "A Wollenberg and C Flohr and D Simon and Cork, {M J} and Thyssen, {J P} and T Bieber and {de Bruin-Weller}, {M S} and S Weidinger and M Deleuran and A Taieb and C Paul and M Trzeciak and T Werfel and J Seneschal and S Barbarot and U Darsow and A Torrelo and J-F Stalder and {\AA} Svensson and D Hijnen and C Gelmetti and Z Szalai and U Gieler and {De Raeve}, L and B Kunz and P Spuls and {von Kobyletzki}, {L B} and R F{\"o}lster-Holst and Chernyshov, {P V} and S Christen-Zaech and A Heratizadeh and J Ring and C Vestergaard",
note = "Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jun,
day = "1",
doi = "10.1111/jdv.16411",
language = "English",
volume = "34",
pages = "e241--e242",
journal = "JEADV : journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "6",
}